This review examines the structure and function of megalin, a large multiligand endocytic receptor in the proximal tubule, covering its roles in protein/vitamin recovery, nephrotoxicity, endocytic dynamics, transcription, and cell metabolism.
Megalin is essential for proximal tubule endocytosis; its absence profoundly impairs membrane and fluid flux through endocytic compartments. New FIB-SEM imaging and machine learning-assisted segmentation challenge the classical model of proximal tubule endocytosis, instead supporting a model involving a continuous dense apical tubule network and the endoplasmic reticulum in regulating ligand passage, fission, and dissociation. Binding of filtered drugs to megalin is identified as a major driver of nephrotoxicity.
As a narrative review, it does not present primary clinical trial data or systematic meta-analytic evidence. Mechanistic insights are largely derived from animal studies and genomic analyses, which may not fully translate to human disease.
Clinicians should be aware that megalin binding of filtered drugs is a major mechanism of nephrotoxicity, with implications for drug safety monitoring in patients with proximal tubule disease. Alterations in megalin expression have complex effects on disease progression and protection, warranting attention in the interpretation of renal biomarker and genomic data.